Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

• 期刊论文

• 出版模式：

  开放获取

• 发表日期：

  2026年7月28日

• Lei Ju,
• Sifeng Gao,
• JiLei Zhang,
• Yuyu Liu,
• Qiang Song,
• Lin Dong,
• Yan Guo,
• Xuemei Qin,
• Jie Zou,
• Chenglu Yuan,
• Yan Shi,
• Dexiao Kong,
• Kaifeng Wang,
• Qiang Li,
• Donglin Yang,
• Qingliang Teng,
• Erlie Jiang,
• Jun Peng,
• Guanchen Bai